Select a dose to see the cheapest documented option that covers it. Providers with verified same-price-across-dose terms are included automatically at every applicable dose; there is no separate flat-price selection. Flat-rate and variable dose-tier providers compete together, with verified required fees included. Comparable monthly, 28-day, 30-day, and four-week injection supplies retain their actual billing labels; no monthly equivalent is invented. Unmatched offers remain visible but unranked. Dose tiers are catalog information, not dosing advice.
Daily compounded liraglutide injection; monthly plan includes up to 90 mg every 60 days, while longer plans include up to 180 mg with shipments every 60 days.; 6-month plan — standard total ($1,074); 6-month plan — paid in full ($894); 12-month plan — standard total ($2,148); 12-month plan — paid in full ($1,428); 12-month prepaid plan — provider-stated monthly equivalent ($119)
Once-daily subcutaneous compounded liraglutide injection; exact concentration and physical shipment quantity are not public.; Separate 1-month provider-subdomain offer ($199)
Daily compounded subcutaneous liraglutide injection, 6 mg/mL in one 7. 5 mL vial (45 mg total). The provider publishes clinician-directed titration through 3 mg daily.
Current compounded liraglutide program; exact route and strength are not stated by the public selector.; 1 Month ($299); 2 Month ($498); Refill — price not public
subcutaneous injection; 5 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.; 0.75mg SQ daily for 4 weeks ($345); 1.35mg SQ daily for 4 weeks ($395); 2.1mg SQ daily for 4 weeks ($495); 2.7mg SQ daily for 4 weeks ($495); 3.3mg SQ daily for 4 weeks ($495)
Compounded liraglutide as a daily subcutaneous injection; default public package is four weeks / 3 mL, with a 6 mL alternative.; Official checkout starting price — 4-week package
Daily compounded liraglutide injection; monthly plan includes up to 90 mg every 60 days, while longer plans include up to 180 mg with shipments every 60 days.; 6-month plan — standard total ($1,074); 6-month plan — paid in full ($894); 12-month plan — standard total ($2,148); 12-month plan — paid in full ($1,428); 12-month prepaid plan — provider-stated monthly equivalent ($119)
Once-daily subcutaneous compounded liraglutide injection; exact concentration and physical shipment quantity are not public.; Separate 1-month provider-subdomain offer ($199)
Daily compounded subcutaneous liraglutide injection, 6 mg/mL in one 7. 5 mL vial (45 mg total). The provider publishes clinician-directed titration through 3 mg daily.
Current compounded liraglutide program; exact route and strength are not stated by the public selector.; 1 Month ($299); 2 Month ($498); Refill — price not public
subcutaneous injection; 5 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.; 0.75mg SQ daily for 4 weeks ($345); 1.35mg SQ daily for 4 weeks ($395); 2.1mg SQ daily for 4 weeks ($495); 2.7mg SQ daily for 4 weeks ($495); 3.3mg SQ daily for 4 weeks ($495)
Compounded liraglutide as a daily subcutaneous injection; default public package is four weeks / 3 mL, with a 6 mL alternative.; Official checkout starting price — 4-week package
Exact current anonymous-store package: Liraglutide 15mg/ml (3ml vial). The exact administration route is not inferred from package nomenclature alone.
Video or phone visit
Regulatory context under reviewSources checked Aug 16, 2026
Regulatory and pricing context
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion. Context source
Displayed prices and dose options are provider-stated snapshots. They may vary by dose, formulation, shipping, state, eligibility, insurance, commitment length, and required subscription. “Not listed” means the reviewed public source did not provide a value.
Information only; not medical advice, a safety evaluation, or a provider endorsement.
Research-use-only suppliers are separate. Their catalog prices never enter the prescription-provider comparison above.